NEU neuren pharmaceuticals limited

Q4 revenue will be 12% royalty (US$250-500 million), Neuren was...

  1. 1,554 Posts.
    lightbulb Created with Sketch. 803
    Q4 revenue will be 12% royalty (US$250-500 million), Neuren was guiding slightly higher revenue for Q4 (US$92+million) which with the current favourable exchange rate will beat guidance of AUD$16-18 million ever so slightly.

    The big difference will be the ~AUD $10 million increase from favourable exchange rate on the US$50 million PRV voucher sale proceeds and the US$50 million milestone payment.

    So CY2024 total somewhere between AUD $227-229 million beating guidance of AUD$216-218 million. I'm lousy at maths so dismantle at your leisure haha
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.31
Change
0.770(6.14%)
Mkt cap ! $1.655B
Open High Low Value Volume
$12.96 $14.00 $12.91 $19.76M 1.453M

Buyers (Bids)

No. Vol. Price($)
1 3000 $13.30
 

Sellers (Offers)

Price($) Vol. No.
$13.33 3716 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.